Incidence, predictors, and prognosis of thrombocytopenia among patients undergoing intra-aortic balloon pumping in the intensive care unit: a propensity score analysis

Wei TONG; Jun-Mei WANG; Jia-Yue LI; Pei-Yao LI; Yun-Dai CHEN; Zheng-Bo ZHANG; Wei DONG

doi:10.11909/j.issn.1671-5411.2021.02.003

Volume 18 Issue 2

Mar. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Geriatric Cardiology > 2021 > 18(2): 123-134

Please cite this article as: TONG W, WANG JM, LI JY, LI PY, CHEN YD, ZHANG ZB, DONG W. Incidence, predictors, and prognosis of thrombocytopenia among patients undergoing intra-aortic balloon pumping in the intensive care unit: a propensity score analysis. J Geriatr Cardiol 2021; 18(2): 123−134. DOI: 10.11909/j.issn.1671-5411.2021.02.003

Citation:

Please cite this article as: TONG W, WANG JM, LI JY, LI PY, CHEN YD, ZHANG ZB, DONG W. Incidence, predictors, and prognosis of thrombocytopenia among patients undergoing intra-aortic balloon pumping in the intensive care unit: a propensity score analysis. J Geriatr Cardiol 2021; 18(2): 123−134. DOI: 10.11909/j.issn.1671-5411.2021.02.003

Citation:

PDF( 3417 KB)

Incidence, predictors, and prognosis of thrombocytopenia among patients undergoing intra-aortic balloon pumping in the intensive care unit: a propensity score analysis

doi: 10.11909/j.issn.1671-5411.2021.02.003

Wei TONG^{1, *},
Jun-Mei WANG^{2, 3, *},
Jia-Yue LI^{1, *},
Pei-Yao LI^{2, 4},
Yun-Dai CHEN¹,
Zheng-Bo ZHANG^{2
,
,},
Wei DONG^{1
,
,}

1.
Department of Cardiology, the Sixth Medical Centre, Chinese PLA General Hospital, Beijing, China
2.
Center for Artificial Intelligence in Medicine, Chinese PLA General Hospital, Beijing, China
3.
CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, China National Center for Bioinformation, Beijing, China
4.
Global Health Drug Discovery Institute, Beijing, China

^*The authors contributed equally to this manuscript

More Information

Corresponding author: zhengbozhang@126.com; dongwei@301hospital.com.cn
Publish Date: 2021-03-05

Abstract

Abstract

OBJECTIVE To explore the incidence, predictors, and prognosis of intra-aortic balloon pumping (IABP)-related thrombocytopenia in critically ill patients. METHODS This multi-center study used the eICU Collaborative Research Database V1.2, comprising data on > 130,000 patients from multiple intensive care units (ICUs) in America between 2014 and 2015. A total of 710 patients undergoing IABP were included. Thrombocytopenia was defined as a drop in platelet count > 50% from baseline. From the cohort, 167 patients who developed thrombocytopenia were matched 1:1 with 167 patients who did not, after propensity score (PS) matching. The associations between IABP-related thrombocytopenia and clinical outcomes were examined by multivariable logistic regression. RESULTS Among 710 patients undergoing IABP, 249 patients (35.07%) developed thrombocytopenia. The APACHE IVa score was a predictor of thrombocytopenia [adjusted odds ratio (OR) = 1.09, 95% confidence interval (CI): 1.02−1.15]. After 1:1 PS matching, in-hospital mortality (adjusted OR = 0.76, 95% CI: 0.37−1.56) and in-ICU mortality (adjusted OR = 0.74, 95% CI: 0.34−1.63) were similar between the thrombocytopenia and non-thrombocytopenia groups. However, major bleeding occurred more frequently in the thrombocytopenia group (adjusted OR = 2.54, 95% CI: 1.54−4.17). In-hospital length of stay (LOS) and in-ICU LOS were significantly longer in patients who developed thrombocytopenia than in those who did not (9.71 vs. 7.36, P < 0.001; 5.13 vs. 2.83, P < 0.001). CONCLUSIONS Among patients undergoing IABP in the ICUs, thrombocytopenia was not associated with a difference in in-hospital mortality or in-ICU mortality; however, thrombocytopenia was significantly associated with a greater risk of major bleeding and increased in-ICU and in-hospital LOS.

FullText(HTML)

References(28)

References

[1]	Stretch R, Sauer CM, Yuh DD, et al. National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis. J Am Coll Cardiol 2014; 64: 1407−1415. doi: 10.1016/j.jacc.2014.07.958
[2]	Trost JC, Hillis LD. Intra-aortic balloon counterpulsation. Am J Cardiol 2006; 97: 1391−1398. doi: 10.1016/j.amjcard.2005.11.070
[3]	van Nunen LX, Noc M, Kapur NK, et al. Usefulness of intra-aortic balloon pump counterpulsation. Am J Cardiol 2016; 117: 469−476. doi: 10.1016/j.amjcard.2015.10.063
[4]	Ferguson JJ 3rd, Cohen M, Freedman RJ Jr, et al. The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. J Am Coll Cardiol 2001; 38: 1456−1462. doi: 10.1016/S0735-1097(01)01553-4
[5]	Parissis H, Graham V, Lampridis S, et al. IABP: history-evolution-pathophysiology-indications: what we need to know. J Cardiothorac Surg 2016; 11: 122. doi: 10.1186/s13019-016-0513-0
[6]	Kapelios CJ, Terrovitis JV, Nanas JN. Current and future applications of the intra-aortic balloon pump. Curr Opin Cardiol 2014; 29: 258−265. doi: 10.1097/HCO.0000000000000059
[7]	Parissis H, Soo A, Al-Alao B. Intra aortic balloon pump: literature review of risk factors related to complications of the intraaortic balloon pump. J Cardiothorac Surg 2011; 6: 147. doi: 10.1186/1749-8090-6-147
[8]	Cohen M, Urban P, Christenson JT, et al. Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry. Eur Heart J 2003; 24: 1763−1770. doi: 10.1016/j.ehj.2003.07.002
[9]	Roy SK, Howard EW, Panza JA, et al. Clinical implications of thrombocytopenia among patients undergoing intra-aortic balloon pump counterpulsation in the coronary care unit. Clin Cardiol 2010; 33: 30−35. doi: 10.1002/clc.20694
[10]	Vonderheide RH, Thadhani R, Kuter DJ. Association of thrombocytopenia with the use of intra-aortic balloon pumps. Am J Med 1998; 105: 27−32. doi: 10.1016/S0002-9343(98)00128-4
[11]	McCabe JC, Abel RM, Subramanian VA, et al. Complications of intra-aortic balloon insertion and counterpulsation. Circulation 1978; 57: 769−773. doi: 10.1161/01.CIR.57.4.769
[12]	Sheng Z, Zhao H, Yan H, et al. Intra-aortic balloon pumping and thrombocytopenia in patients with acute coronary syndrome: incidence, risk factors, and prognosis. Herz 2018; 43: 555−564. doi: 10.1007/s00059-017-4599-5
[13]	Essay P, Shahin TB, Balkan B, et al. The connected intensive care unit patient: exploratory analyses and cohort discovery from a critical care telemedicine database. JMIR Med Inform 2019; 7: e13006. doi: 10.2196/13006
[14]	McShea M, Holl R, Badawi O, et al. The eICU research institute: a collaboration between industry, health-care providers, and academia. IEEE Eng Med Biol Mag 2010; 29: 18−25. doi: 10.1109/MEMB.2009.935720
[15]	Pollard TJ, Johnson AEW, Raffa JD, et al. The eICU Collaborative Research Database, a freely available multi-center database for critical care research. Sci Data 2018; 5: 180178. doi: 10.1038/sdata.2018.178
[16]	Vincent JL, Moreno R. Clinical review: scoring systems in the critically ill. Crit Care 2010; 14: 207. doi: 10.1186/cc8204
[17]	Vora AN, Chenier M, Schulte PJ, et al. Long-term outcomes associated with hospital acquired thrombocytopenia among patients with non-ST-segment elevation acute coronary syndrome. Am Heart J 2014; 168: 189−196.e1. doi: 10.1016/j.ahj.2014.04.010
[18]	De Labriolle A, Bonello L, Lemesle G, et al. Decline in platelet count in patients treated by percutaneous coronary intervention: definition, incidence, prognostic importance, and predictive factors. Eur Heart J 2010; 31: 1079−1087. doi: 10.1093/eurheartj/ehp594
[19]	Wang TY, Ou FS, Roe MT, et al. Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice. Circulation 2009; 119: 2454−2462. doi: 10.1161/CIRCULATIONAHA.108.827162
[20]	Caixeta A, Dangas GD, Mehran R, et al. Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. Am Heart J 2011; 161: 298−306.e1. doi: 10.1016/j.ahj.2010.10.035
[21]	Bream-Rouwenhorst HR, Hobbs RA, Horwitz PA. Thrombocytopenia in patients treated with heparin, combination antiplatelet therapy, and intra-aortic balloon pump counterpulsation. J Interv Cardiol 2008; 21: 350−356. doi: 10.1111/j.1540-8183.2008.00363.x
[22]	Sekhon SS, Roy V. Thrombocytopenia in adults: a practical approach to evaluation and management. South Med J 2006; 99: 491−498. doi: 10.1097/01.smj.0000209275.75045.d4
[23]	Hui P, Cook DJ, Lim W, et al. The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest 2011; 139: 271−278. doi: 10.1378/chest.10-2243
[24]	Jang IK, Hursting MJ. When heparins promote thrombosis: review of heparin-induced thrombocytopenia. Circulation 2005; 111: 2671−2683. doi: 10.1161/CIRCULATIONAHA.104.518563
[25]	EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997; 336: 1689−1696. doi: 10.1056/NEJM199706123362401
[26]	Crowther MA, Cook DJ, Meade MO, et al. Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors. J Crit Care 2005; 20: 348−353. doi: 10.1016/j.jcrc.2005.09.008
[27]	Ben Hamida C, Lauzet JY, Rézaiguia-Delclaux S, et al. Effect of severe thrombocytopenia on patient outcome after liver transplantation. Intensive Care Med 2003; 29: 756−762. doi: 10.1007/s00134-003-1727-x
[28]	Fountain EM, Arepally GM. Etiology and complications of thrombocytopenia in hospitalized medical patients. J Thromb Thrombolysis 2017; 43: 429−436. doi: 10.1007/s11239-016-1467-8